pathogenesis tb
TRANSCRIPT
-
7/29/2019 Pathogenesis TB
1/39
Pathogenesis TB In
Children
HMS Chandra Kusuma
Pediatric Departement Of Fac. Med. Brawijaya Univ.
Saiful Anwar General Hospital
-
7/29/2019 Pathogenesis TB
2/39
Definition
Tuberculosis is a disease due toMycobacterium tuberculosis
infection with systemic spread thuscan affect almost all organs, andthe most frequent site is in the
lung, which usually as the site ofprimary infection
-
7/29/2019 Pathogenesis TB
3/39
Tuberculosis
The reaction of the tissues of the
human host to the presenceand multiplication ofMycobacterium tuberculosisor
Mycobacterium bovis
-
7/29/2019 Pathogenesis TB
4/39
History ancient Egypt : gibbus
1882, Koch, identification
management : sanatorium, collapsetreatment
Chemotherapy : PAS 1943 Lehmann
Streptomycine 1945 - Waksman & Schats
Isoniazid 1952 Domagk
Rifampicine - 1957
-
7/29/2019 Pathogenesis TB
5/39
Magnitude of problem
TB one of the oldest diseases of human
remains one of the deadliest diseases in
the world 8 million of new cases yearly
3 million death yearly
20-40% population is infected reemergence, global emergency
-
7/29/2019 Pathogenesis TB
6/39
The secret
Why TB is so strong & robust?
the secret: specific characters of
the bacilli special issues:
hematogenic spread
infection vs disease
primary vs post-primary
-
7/29/2019 Pathogenesis TB
7/39
Etiology
-
7/29/2019 Pathogenesis TB
8/39
The bacilli Mycobacterium tuberculosis Mycobacterium bovis
features:
slender, often slightly curved, rods aerobic, non-motile, non-spore forming
acid fail to wash the stain out acid fast bacilli
Mycobacteria : found in environments, somestrictly human pathogen (M tb, bovis), othersanimal pathogen and opportunistic pathogens inhuman (atypical mycobacteria)
-
7/29/2019 Pathogenesis TB
9/39
TB bacilli
-
7/29/2019 Pathogenesis TB
10/39
M tuberculosisUnique characteristics :
1. live in weeks in dry condition
2. no endotoxins, no exotoxins
3. hematogenic spread
4. grows slowly (24-32 hr)
5. non specific clinical manifestation6. aerob, organ predilection - lung
7. wide spectrum of replication: dormant
-
7/29/2019 Pathogenesis TB
11/39
Transmission
-
7/29/2019 Pathogenesis TB
12/39
Transmission ...
airborne human to human transmission bydroplet nuclei
adult pulmonary TB: cough, sneeze, speak, orsing
droplet nuclei : contain 2-3 bacilli, small size(1-5) keep in the air for long period
inhalation, reach alveoli
middle and lower lobes
-
7/29/2019 Pathogenesis TB
13/39
TB droplet nuclei
-
7/29/2019 Pathogenesis TB
14/39
Transmission factors:
doses / numbers
concentration in the air virulence
exposure duration
host immune state
-
7/29/2019 Pathogenesis TB
15/39
Infection source
Known source of infection, has
diagnostic value
Shaw (1954), transmission rate:AFB (+) : 62.5 %
AFB (-), M tb (+) : 26.8 %
AFB (-), M tb (-) : 17.6 %
-
7/29/2019 Pathogenesis TB
16/39
Transmission rate(Shaw 54)adult
TB patient
AFB(+)AFB(-)
culture(+)culture(-)CXR (+)
65% 26% 17%
-
7/29/2019 Pathogenesis TB
17/39
Pathogenesis
-
7/29/2019 Pathogenesis TB
18/39
Location of primary focus
in 2,114 cases, 1909-1928
Location %
Lung 95.93
Intestine 1.14
Skin 0.14Nose 0.09
Tonsil 0.09
Middle ear (Eustachian tube) 0.09Parotid 0.05
Conjunctiva 0.05
Undetermined 2.41
-
7/29/2019 Pathogenesis TB
19/39Figure. Pathogenesis of primary tuberculosis
droplet nuclei
inhalation
alveoli ingestion by PAMS
intracellular replication
of bacilli
destructionof bacillidestruction of PAMS
Tubercle formation Hilar lymph nodes
hematogenic spread
multiple organsremote foci
Lymphogenic spread
disseminated primary TB
acute hematogenicspread
occult hematogenicspread
primary focus lymphangitis lymphadenitis
primary
complex
CMI
Pathogenesis
-
7/29/2019 Pathogenesis TB
20/39
PathogenesisM tuberculosisinoculation
phagocytocis by PAMM tbdestroyed
M tbsurvive, replicate
primary focus formation
lymphogenic spread
hematogenous spread
primary complex
CMI (+)
complication of:(1)primary complex, (2)lymphogenic
and (3)hematogenous spreadoptimal immunity
TB disease TB infection
death cured TB disease
tuberculin test (+)
primaryTB
postprimary
TB
reactivation
/ reinfection
incubationperiod
2-12weeks
-
7/29/2019 Pathogenesis TB
21/39
Incubation period
first implantation primary complex
4-6 weeks (2-12 weeks) incubation period
first weeks: logaritmic growth, : 103-10
4
elicit cellular response
end of incubation period:
primary complex formation
cell mediated immunity tuberculin sensitivity
Primary TB infection has established
-
7/29/2019 Pathogenesis TB
22/39
Hematogenous spread
during incubation period, before TBinfection establishment:
lymphogenic spread hematogenic spread
hematogenic spread (HS):
occult HS acute generalized HS
-
7/29/2019 Pathogenesis TB
23/39
Occult HS
most common sporadic, small number
no immediate clinical manifestation
remote foci in almost every organ rich vascularization: brain, liver, bones &
joints, kidney
including: lung apex region (Simon focus)
CMI (+): silent foci - dormant, potential forreactivation
-
7/29/2019 Pathogenesis TB
24/39
lymphadenitis
lymphangitis
primary focus
Pathogenesis...
Ghon focus
Simon focus
-
7/29/2019 Pathogenesis TB
25/39
TB hematogenous spread
-
7/29/2019 Pathogenesis TB
26/39
Acute HS
less common
large number
immediate clinical manifestation:disseminated TB
milliary TB, meningitis TB
tubercle in same size, specialappearance in CXR
-
7/29/2019 Pathogenesis TB
27/39
Miliary TB
-
7/29/2019 Pathogenesis TB
28/39
Primary complex
end of incubation period
TB infection establishment
tuberculin sensitivity (DTH)
cell mediated immunity
end of hematogenic spread
end of TB bacilli proliferation
small amount, live dormant in granuloma
new exogenous TB bacilli: destroyed / localized
-
7/29/2019 Pathogenesis TB
29/39
TB infection & TB disease
TB infection: CMI can control infection
primary complex (+)
cell mediated immunity (+)
tuberculin sensitivity (DTH) (+)
limited amount of TB bacilli
no clinical or radiological manifestation
TB disease:CMI failed to control TB infectionTB infection + clinical and/or radiologicalmanifestation
-
7/29/2019 Pathogenesis TB
30/39
TB infection
TB CMI
-
7/29/2019 Pathogenesis TB
31/39
TB disease
TB
CMI
-
7/29/2019 Pathogenesis TB
32/39
TB classification(ATS/CDC modified)Class Contact Infection Disease Treatment
0 - - - -
1 + - - proph I
2 + + - proph II?
3 + + + therapy
-
7/29/2019 Pathogenesis TB
33/39
TB natural history overview
primary TB infection
primary TB disease latent TB infection
no diseasepost primary TB
respiratory TBnon respir TB
new infection
-
7/29/2019 Pathogenesis TB
34/39
Prognostic factors
A. TB bacilli : virulence infection dose
B. Patient : general condition
age
nutritional state
coinfection: morbili, pertussis genetic
stress; physically (trauma, surgery) ormentally
-
7/29/2019 Pathogenesis TB
35/39
Pathology
-
7/29/2019 Pathogenesis TB
36/39
Pathology
complicated pathogenesisvaried pathology
clinical manifestation
radiologic appearance lung represent
tubercle, granuloma, tuberculoma, fibrosis,
fistula, cavity, atelectasis complication of primary focus: so many
possibilities
-
7/29/2019 Pathogenesis TB
37/39
Lesions of pulmonary TB
Parenchym: primary focus, pneumonia,atelectasis, tuberculoma, cavitary
Lymph node: hilar, paratracheal, mediastinal
Airway: air trapping, endobronchial TB,bronchial stenosis, fistula, bronchiectasis
Pleura: effusion, fistula, empyema,
pneumothorax, hemothorax Blood vessels: milliary, hemorrhage
-
7/29/2019 Pathogenesis TB
38/39
tubercle formationresolution
primary focus
calcification
2nd lung lesions
caseation
liquefaction
granuloma
Pathology jungle
remote focireg lymph node
tuberculoma
cavity
milliary seed
erodes airway
compresses airway
rupt to pleura rupt to airwaybronchiectasis
fibrosis
br pl fistula
-
7/29/2019 Pathogenesis TB
39/39
Thank you